Search - tctmd.com

Displaying 61 - 80 of 136

Sort: Relevancy | Date

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Caitlin E. Cox

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Another Win for PREVENT, This Time in Older Adults

Yael L. Maxwell

May 06, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Caitlin E. Cox

May 01, 2025

News Conference News HRS 2025

CRT Patients Fare Better With LBB Area vs Biventricular Pacing

Todd Neale

April 30, 2025

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

News Daily News

HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation

Todd Neale

April 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

Black Adults Face CV Mortality Beyond Their Predicted Risk

Caitlin E. Cox

April 18, 2025

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Daily News

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

L.A. McKeown

April 14, 2025

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Caitlin E. Cox

April 14, 2025

News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Michael O'Riordan

April 10, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Conference News ACC 2025

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

Michael O'Riordan

April 08, 2025

Advertisement

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Another Win for PREVENT, This Time in Older Adults

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

Access to GLP-1 Drugs Unequal for US Patients With Obesity

CRT Patients Fare Better With LBB Area vs Biventricular Pacing

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation

April 2025 Dispatch for the CV Team

Black Adults Face CV Mortality Beyond Their Predicted Risk

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Weekend Warriors Also See Mortality Benefits With Exercise

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content